Candidate gene
Marker
Therapy target
|
System | Type | Disorder | Pubmed |
psychiatry | | | |
PDE2A inhibitors could be used as pharmacological drugs for treatment of anxiety and nicotine addiction via their actions on medial habenula (MHb) axonal terminals | miscelleaneous | vascular | | |
targeting PDE2A may provide a new therapeutic approach in diseases associated with endothelial dysfunction, oxidative stress, vascular proliferation, and angiogenesis | respiratory | | | |
inhibition of PDE2A is of potential therapeutic interest in sepsis and acute respiratory distress syndrome (ARDS) |
| | | |